These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 27439913)
1. NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications. Angelino G; De Pasquale MD; De Sio L; Serra A; Massimi L; De Vito R; Marrazzo A; Lancella L; Carai A; Antonelli M; Giangaspero F; Gessi M; Menchini L; Scarciolla L; Longo D; Mastronuzzi A BMC Cancer; 2016 Jul; 16():512. PubMed ID: 27439913 [TBL] [Abstract][Full Text] [Related]
6. The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort. Ekedahl H; Cirenajwis H; Harbst K; Carneiro A; Nielsen K; Olsson H; Lundgren L; Ingvar C; Jönsson G Br J Dermatol; 2013 Nov; 169(5):1049-55. PubMed ID: 23855428 [TBL] [Abstract][Full Text] [Related]
7. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases. Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561 [TBL] [Abstract][Full Text] [Related]
8. Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature. Martin-Blondel G; Rousseau A; Boch AL; Cacoub P; Sène D Clin Neuropathol; 2009; 28(5):387-94. PubMed ID: 19788056 [TBL] [Abstract][Full Text] [Related]
9. Primary leptomeningeal melanomatosis: early leptomeningeal enhancement on MRI. Celli P; Acqui M; Trillò G; Ramundo EO; D'Andrea G; Roperto R; Ferrante L J Neurosurg Sci; 2001 Dec; 45(4):235-40. PubMed ID: 11912478 [TBL] [Abstract][Full Text] [Related]
10. Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects. Küsters-Vandevelde HV; Küsters B; van Engen-van Grunsven AC; Groenen PJ; Wesseling P; Blokx WA Brain Pathol; 2015 Mar; 25(2):209-26. PubMed ID: 25534128 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic challenges of primary diffuse leptomeningeal melanomatosis in early adolescence: A case report. Yamauhci S; Fukuyama T; Inaba Y; Nakajima H; Hattori Y; Miyairi Y; Ogiso Y Brain Dev; 2022 Jun; 44(6):421-425. PubMed ID: 35260265 [TBL] [Abstract][Full Text] [Related]
12. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294 [TBL] [Abstract][Full Text] [Related]
13. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas. Uguen A; Talagas M; Costa S; Samaison L; Paule L; Alavi Z; De Braekeleer M; Le Marechal C; Marcorelles P Diagn Pathol; 2015 Jul; 10():121. PubMed ID: 26204954 [TBL] [Abstract][Full Text] [Related]
14. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases. Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687 [TBL] [Abstract][Full Text] [Related]
15. Primary Amelanotic Leptomeningeal Melanomatosis in a Child: A Rare but Severe Disease. Szathmari A; Perbet R; Hermier M; Di Rocco F; Frappaz D; Mottolese C World Neurosurg; 2016 Aug; 92():581.e15-581.e20. PubMed ID: 27319310 [TBL] [Abstract][Full Text] [Related]
16. Primary central nervous system malignant melanoma with leptomeningeal melanomatosis: a case report and review of the literature. Fujimori K; Sakai K; Higashiyama F; Oya F; Maejima T; Miyake T Neurosurg Rev; 2018 Jan; 41(1):333-339. PubMed ID: 28986666 [TBL] [Abstract][Full Text] [Related]
18. Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomas. Fortin Ensign S; Bollin K; Millis SZ; Hinds BR; Kosty M; Uchiyama C Pigment Cell Melanoma Res; 2020 May; 33(3):458-465. PubMed ID: 31663661 [TBL] [Abstract][Full Text] [Related]
19. An NRAS mutation in primary malignant melanoma of the lung: a case report. Hibiya T; Tanaka M; Matsumura M; Aoki A; Ikegami T; Okudela K; Kawano N; Ohashi K Diagn Pathol; 2020 Feb; 15(1):11. PubMed ID: 32028967 [TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma. Pracht M; Mogha A; Lespagnol A; Fautrel A; Mouchet N; Le Gall F; Paumier V; Lefeuvre-Plesse C; Rioux-Leclerc N; Mosser J; Oger E; Adamski H; Galibert MD; Lesimple T J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1530-8. PubMed ID: 25623140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]